Peptide dose ranges compared
Every peptide on the site that has a numeric, sourced typical dose is shown here as a bar, grouped by its unit so the bars in each group share one scale. It lets you compare the dose range of one peptide against another at a glance — not how strong or effective they are. A bigger number is not a stronger or better drug: different peptides work at completely different doses, which is exactly why those in different units are kept apart. Each range carries its own source, and opening an entry shows what that dose was studied or approved for. No dose here is a recommendation.
Doses in milligrams (mg) 57
Log scale: each step to the right is about a tenfold larger dose. A bar further right sits at a higher dose in mg; a wider bar spans a wider range. Doses in this group span several orders of magnitude, so a straight scale would flatten the smaller ones to nothing.
- Trofinetide5000–12000 mgApproved label
- Thymomodulin80–800 mgHuman study
- D-4F100–500 mgHuman study
- Maridebart cafraglutide140–420 mgHuman study
- Ramoplanin100–400 mgHuman study
- Elagolix150–200 mgApproved label
- Lixivaptan25–100 mgHuman study
- Avexitide30–90 mgHuman study
- ECC50045–75 mgHuman study
- Amycretin1.25–60 mgHuman study
- Albiglutide30–50 mgHuman study
- Efruxifermin28–50 mgHuman study
- Bofanglutide12–48 mgHuman study
- Insulin tregopil30–45 mgHuman study
- Nemifitide30–45 mgHuman study
- Pegozafermin15–44 mgHuman study
- Glatiramer Acetate20–40 mgApproved label
- Pegbelfermin10–40 mgHuman study
- Zilucoplan16.6–32.4 mgApproved label
- Efmedaglutide alfa15–30 mgHuman study
- Pegvisomant10–30 mgApproved label
- Emodepside5–30 mgHuman study
- MK-67710–25 mgHuman study
- Triptorelin3.75–22.5 mgApproved label
- Taspoglutide10–20 mgHuman study
- Tiplimotide5–20 mgHuman study
- Detirelix1–20 mgHuman study
- Orforglipron0.8–17.2 mgApproved label
- Avorelin10–15 mgHuman study
- Etelcalcetide2.5–15 mgApproved label
- Tirzepatide2.5–15 mgApproved label
- VK27352.5–15 mgHuman study
- Enicepatide5–12 mgHuman study
- KN0560.5–12 mgHuman study
- Prostatilen5–10 mgHuman study
- Metreleptin2.5–10 mgApproved label
- Eloralintide1–9 mgHuman study
- Larazotide0.5–8 mgHuman study
- Efpeglenatide4–6 mgHuman study
- Survodutide2.4–6 mgHuman study
- UBT2512–6 mgHuman study
- HRS-95310.9–5.4 mgHuman study
- Pegsebrenatide2.5–5 mgHuman study
- C-peptide1.5–4.5 mgHuman study
- Dulaglutide0.75–4.5 mgApproved label
- Cagrilintide0.3–4.5 mgHuman study
- Livoletide3–4 mgHuman study
- Efsubaglutide alfa1–3 mgHuman study
- Liraglutide0.6–3 mgApproved label
- Setmelanotide0.5–3 mgApproved label
- Edratide0.5–2.5 mgHuman study
- Pemvidutide1.2–2.4 mgHuman study
- Ecnoglutide0.6–2.4 mgHuman study
- Semaglutide0.25–2.4 mgApproved label
- Thymodepressin1–2 mgApproved label
- Tesofensine0.25–1 mgHuman study
- Pasireotide0.3–0.9 mgApproved label
Doses in micrograms (mcg) 14
Log scale: each step to the right is about a tenfold larger dose. A bar further right sits at a higher dose in mcg; a wider bar spans a wider range. Doses in this group span several orders of magnitude, so a straight scale would flatten the smaller ones to nothing.
- Canvuparatide200–900 mcgHuman study
- Parathyroid hormone-related protein400–600 mcgHuman study
- Cotadutide100–600 mcgHuman study
- Ebiratide60–600 mcgHuman study
- Octreotide50–500 mcgApproved label
- Polyethylene glycol loxenatide100–200 mcgHuman study
- Pramlintide15–120 mcgApproved label
- Parathyroid hormone (1-84)25–100 mcgApproved label
- Urocortin 225–100 mcgHuman study
- Eneboparatide10–80 mcgHuman study
- Dalazatide30–60 mcgHuman study
- CP0410–50 mcgHuman study
- Rusalatide1–10 mcgHuman study
- Alprostadil1.25–2.5 mcgApproved label
Weight-based doses (mg per kg) 8
Log scale: each step to the right is about a tenfold larger dose. A bar further right sits at a higher dose in mg/kg; a wider bar spans a wider range. Doses in this group span several orders of magnitude, so a straight scale would flatten the smaller ones to nothing.
- Tabimorelin1.71–6.86 mg/kgHuman study
- Daptomycin4–6 mg/kgApproved label
- Zelpultide alfa2–6 mg/kgHuman study
- ACE-0310.02–3 mg/kgHuman study
- Sotatercept0.3–0.7 mg/kgApproved label
- IGF-10.04–0.12 mg/kgApproved label
- Mecasermin0.04–0.12 mg/kgApproved label
- Pegmolesatide0.04–0.08 mg/kgHuman study
Weight-based doses (mcg per kg) 4
Log scale: each step to the right is about a tenfold larger dose. A bar further right sits at a higher dose in mcg/kg; a wider bar spans a wider range. Doses in this group span several orders of magnitude, so a straight scale would flatten the smaller ones to nothing.
- Romiplostim1–10 mcg/kgApproved label
- Alexamorelin1–2 mcg/kgHuman study
- Growth hormone-releasing hormone1–2 mcg/kgHuman study
- Secretin0.2–0.4 mcg/kgApproved label
How to read this
The bars compare the span of each peptide's typical dose within one unit, on a scale from zero to the highest dose in that group. They do not say anything about potency, how well a peptide works, or how one compares to another in effect — a peptide dosed in micrograms is not weaker than one dosed in milligrams, and the two are not shown together for that reason. Each row's source tag says where the range comes from: an approved label, a human trial, a community report or an animal study. For the full picture, open the entry and its goal or the name decoder.